Results 61 to 70 of about 2,702,692 (201)
OPTN interacts with NRF2 to facilitate the AKT/DRP1‐mediated regulation of mitochondrial fission in the cytoplasm of SCAPs, promoting tooth root mineralisation. Additionally, OPTN maintains NRF2's nuclear translocation, enhancing the transcriptional regulation of downstream BCL2, ultimately leading to the inhibition apoptosis in SCAPs and regulate ...
Haojie Liu+9 more
wiley +1 more source
Paget's disease of bone (PDB) is a chronic localized bone disorder in an elderly population. Environmental factors such as paramyxovirus are implicated in PDB and measles virus nucleocapsid protein (MVNP) has been shown to induce pagetic osteoclasts ...
Kumaran Sundaram+4 more
doaj +1 more source
General analysis of mathematical models for bone remodeling [PDF]
Bone remodeling is regulated by pathways controlling the interplay of osteoblasts and osteoclasts. In this work, we apply the method of generalized modelling to systematically analyse a large class of models of bone remodeling. Our analysis shows that osteoblast precursors can play an important role in the regulation of bone remodeling.
arxiv
First‐line treatment of osteoporosis with osteoanabolic therapy: a new opportunity
Abstract Osteoporosis is a national health priority, and over six million Australians over the age of 50 years have poor bone health. Fragility fractures due to osteoporosis are associated with an increased morbidity and mortality risk and a high economic cost to the community. It is a chronic condition requiring long‐term management.
Jasna Aleksova, Peter Ebeling
wiley +1 more source
Paget's disease of bone: An entity still exists in India
Background: Paget's disease of bone (PDB) is uncommonly reported from India. We attempted to study the clinical and imaging features and management of participants who presented with PDB.
Kripa Elizabeth Cherian+9 more
doaj +1 more source
Molecular effect of an OPTN common variant associated to Paget's disease of bone. [PDF]
Paget's disease of bone (PDB) is a chronic bone disorder and although genetic factors appear to play an important role in its pathogenesis, to date PDB causing mutations were identified only in the Sequestosome 1 (SQSTM1) gene at the PDB3 locus.
Iris A L Silva+5 more
doaj +1 more source
TREATMENT OF PAGET'S DISEASE OF BONE [PDF]
There are two major types of agent available to suppress disease activity: calcitonin, and the bisphosphonates (formerly called diphosphonates). Other agents, including fluoride, mithramycin, actinomycin-D, glucocorticoids, colchicine, glucagon and inosiplex, have also been investigated, but are either ineffective, toxic or ...
D. C. Anderson, J A Cantrill
openaire +5 more sources
Abstract Background Paget's disease of the bone (PDB) is a metabolic bone disorder involving one or more skeletal sites. Cardiovascular diseases (CVDs) have been described in patients with PDB but have not been systematically analysed. Objectives This study aimed to compare standard and advanced (speckle‐tracking) echocardiographic parameters measured ...
Alfonso Giaquinto+13 more
wiley +1 more source
Craniodiaphyseal dysplasia, a very rare form of bone dysplasia
Introduction: Craniodiaphyseal dysplasia is a very rare autosomal recessive disorder which is typically presented in infancy and characterised by severe form of bone dysplasia, massive bone sclerosis and hyperostosis.
Bayar Ahmed Qasim+4 more
doaj
VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. [PDF]
Dominant mutations in the valosin containing protein (VCP) gene cause inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD). We have generated a knock-in mouse model with the common R155H mutation.
Mallikarjun Badadani+12 more
doaj +1 more source